Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Plexium Inc.
Headquarters: San Diego, CA, United States of America
Website: https://www.plexium.com/
Year Founded: 2017
Status: Private
BioCentury | Nov 21, 2024
Management Tracks
Boshoff to succeed Dolsten as Pfizer CSO
Plus: Hwang joins Metaphore, Flagship and updates from FDA, MHRA, ArrePath, ABT, Unnatural, Thryv and more
BioCentury | Apr 18, 2024
Product Development
CDK2 inhibitors at AACR: An answer to CDK4/6 resistance?
AACR abstracts highlight CDK2 inhibition as solution to CDK4/6 resistance and route to reaching more cancer types
BioCentury | Dec 12, 2023
Deals
Dec. 11 Quick Takes: BMS paying $800M up front for SystImmune’s bispecific ADC
Plus: Pain, hearing loss company Hoba raises €23M and more from Novartis, Cogent and Zafrens
BioCentury | Sep 19, 2023
Emerging Company Profile
Magnet: taking molecular glues beyond protein degradation with $50M
The company discovers small molecules that induce desired protein-protein interactions using an arsenal of screening technologies
BioCentury | Nov 11, 2022
Product Development
Molecular glue degraders: moving beyond IMiDs
Technologies unraveling the relationships between glue structures and conformational changes are opening up new targets and E3 ligases
BioCentury | Sep 22, 2022
Emerging Company Profile
Triana: Molecular glues for degradation and beyond
Launched this spring with $110M, the biotech discovers small molecule and macrocyclic molecular glues using machine learning and DEL screening
BioCentury | Aug 24, 2022
Management Tracks
Bluebird’s Eggimann joins Tessera team
Plus new board appointments at GSK and Alnylam, and updates from Zealand, Pharus and more
BioCentury | May 4, 2022
Management Tracks
Hickey returns to U.S. for new role at Pfizer
Plus Kaundinya named president and CEO at GlycoERA, and updates from Plexium, Alentis, ADCendo, Xcell and more
BioCentury | Apr 29, 2022
Product Development
April 28 Quick Takes: Pfizer enrolling DMD trial after FDA lifts hold
Plus FDA approves AZ’s Ultomiris for gMG and updates from Gilead, Cytovia and more
Items per page:
1 - 10 of 21